TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
UTHR

United Therapeutics Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

475.50$ +0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

United Therapeutics Corporation (UTHR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 783 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement UTHR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
609 615 678 715 749 736 794 799 800 790 782 783 3,155
70 71 73 78 83 76 93 88 101 103 133 100 437
539 544 605 637 666 660 702 711 699 687 648 684 2,717
85 151 104 140 104 134 149 134 128 140 138 146 552
107 108 121 152 199 136 144 160 154 157 155 138 604
212 284 249 317 323 302 319 347 309 329 322 353 1,314
327 260 356 320 343 358 383 365 389 358 326 331 1,403
16 15 13 12 10 7.9 6.1 7.3 3.0 3.1 3.0 2.9 12
352 295 399 355 389 397 424 408 438 444 318 373 1,573
84 78 92 77 80 95 101 99 99 80 43 40 262
268 217 307 278 309 301 322 310 339 364 275 333 1,311
381 324 427 386 418 424 437 437 463 470 344 376 1,652

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?